---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-356168"
form_type: "8-K"
ticker: "MREO"
cik: "0001719714"
company_name: "Mereo BioPharma Group plc"
filed_at: "2026-08-19T11:52:29+00:00"
generated_at: "2026-08-19T11:55:20.040234+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Mereo BioPharma gets second Nasdaq notice; extra 180 days to meet $1 bid price

## Summary
- Received second Nasdaq notice on Aug 18, 2026; new compliance deadline Feb 16, 2027.
- Must close at $1.00+ for 10 consecutive business days to regain compliance.
- If not compliant by Feb 16, 2027, Nasdaq will issue delisting notice; company may appeal.
- First notice received Feb 17, 2026; initial 180-day period expired Aug 17, 2026.
- Company monitoring bid price and considering options to regain compliance.

## SEC filing metadata
- accession: 0001193125-26-356168
- form_type: 8-K
- ticker: MREO
- cik: 0001719714
- company_name: Mereo BioPharma Group plc
- filed_at: 2026-08-19T11:52:29+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719714/000119312526356168/0001193125-26-356168-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719714/000119312526356168/mreo-20260217.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-356168
- JSON: https://secwatch.observer/filing/0001193125-26-356168.json
- Plain text: https://secwatch.observer/filing/0001193125-26-356168.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.